vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $32.0M, roughly 1.2× Silvercrest Asset Management Group Inc.). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -161.8%, a 161.4% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs -0.0%). Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $-71.3M).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
IBRX vs SAMG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $32.0M |
| Net Profit | $-61.9M | $-120.0K |
| Gross Margin | 99.0% | — |
| Operating Margin | -169.0% | -2.8% |
| Net Margin | -161.8% | -0.4% |
| Revenue YoY | 407.0% | -0.0% |
| Net Profit YoY | -4.7% | -107.4% |
| EPS (diluted) | $-0.06 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $32.0M | ||
| Q3 25 | $32.1M | $31.3M | ||
| Q2 25 | $26.4M | $30.7M | ||
| Q1 25 | $16.5M | $31.4M | ||
| Q4 24 | $7.6M | $32.0M | ||
| Q3 24 | $6.1M | $30.4M | ||
| Q2 24 | — | $31.0M | ||
| Q1 24 | — | $30.3M |
| Q4 25 | $-61.9M | $-120.0K | ||
| Q3 25 | $-67.3M | $618.0K | ||
| Q2 25 | $-92.6M | $1.9M | ||
| Q1 25 | $-129.6M | $2.5M | ||
| Q4 24 | $-59.2M | $1.6M | ||
| Q3 24 | $-85.7M | $2.3M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | 99.0% | — | ||
| Q3 25 | 99.4% | — | ||
| Q2 25 | 99.5% | — | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -169.0% | -2.8% | ||
| Q3 25 | -173.5% | 4.3% | ||
| Q2 25 | -269.8% | 13.2% | ||
| Q1 25 | -390.1% | 15.4% | ||
| Q4 24 | -919.0% | 6.1% | ||
| Q3 24 | -1314.3% | 14.6% | ||
| Q2 24 | — | 17.1% | ||
| Q1 24 | — | 19.5% |
| Q4 25 | -161.8% | -0.4% | ||
| Q3 25 | -209.8% | 2.0% | ||
| Q2 25 | -350.3% | 6.3% | ||
| Q1 25 | -784.9% | 7.9% | ||
| Q4 24 | -783.4% | 5.1% | ||
| Q3 24 | -1404.0% | 7.4% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 9.9% |
| Q4 25 | $-0.06 | $0.02 | ||
| Q3 25 | $-0.07 | $0.07 | ||
| Q2 25 | $-0.10 | $0.21 | ||
| Q1 25 | $-0.15 | $0.26 | ||
| Q4 24 | $-0.08 | $0.16 | ||
| Q3 24 | $-0.14 | $0.24 | ||
| Q2 24 | — | $0.28 | ||
| Q1 24 | — | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | $44.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-500.5M | $50.3M |
| Total Assets | $501.9M | $166.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | $44.1M | ||
| Q3 25 | $257.8M | $36.1M | ||
| Q2 25 | $153.7M | $30.0M | ||
| Q1 25 | $61.6M | $36.3M | ||
| Q4 24 | $149.8M | $68.6M | ||
| Q3 24 | $130.4M | $58.1M | ||
| Q2 24 | — | $49.9M | ||
| Q1 24 | — | $39.7M |
| Q4 25 | $-500.5M | $50.3M | ||
| Q3 25 | $-524.3M | $58.9M | ||
| Q2 25 | $-570.7M | $64.6M | ||
| Q1 25 | $-591.4M | $80.0M | ||
| Q4 24 | $-489.1M | $80.7M | ||
| Q3 24 | $-745.1M | $84.6M | ||
| Q2 24 | — | $85.3M | ||
| Q1 24 | — | $83.9M |
| Q4 25 | $501.9M | $166.6M | ||
| Q3 25 | $519.0M | $157.6M | ||
| Q2 25 | $402.1M | $152.7M | ||
| Q1 25 | $303.8M | $159.9M | ||
| Q4 24 | $382.9M | $194.4M | ||
| Q3 24 | $364.6M | $184.2M | ||
| Q2 24 | — | $177.6M | ||
| Q1 24 | — | $170.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $18.6M |
| Free Cash FlowOCF − Capex | $-71.3M | $15.0M |
| FCF MarginFCF / Revenue | -186.2% | 46.9% |
| Capex IntensityCapex / Revenue | 2.4% | 11.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | $17.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $18.6M | ||
| Q3 25 | $-68.9M | $14.6M | ||
| Q2 25 | $-79.7M | $13.8M | ||
| Q1 25 | $-85.9M | $-24.7M | ||
| Q4 24 | $-85.1M | $21.6M | ||
| Q3 24 | $-98.8M | $13.3M | ||
| Q2 24 | — | $16.0M | ||
| Q1 24 | — | $-24.1M |
| Q4 25 | $-71.3M | $15.0M | ||
| Q3 25 | $-69.6M | $13.8M | ||
| Q2 25 | $-80.8M | $13.4M | ||
| Q1 25 | $-87.0M | $-25.1M | ||
| Q4 24 | $-87.3M | $19.9M | ||
| Q3 24 | $-101.6M | $12.9M | ||
| Q2 24 | — | $15.6M | ||
| Q1 24 | — | $-24.7M |
| Q4 25 | -186.2% | 46.9% | ||
| Q3 25 | -217.2% | 44.1% | ||
| Q2 25 | -305.9% | 43.6% | ||
| Q1 25 | -526.9% | -80.0% | ||
| Q4 24 | -1155.4% | 62.2% | ||
| Q3 24 | -1663.2% | 42.4% | ||
| Q2 24 | — | 50.4% | ||
| Q1 24 | — | -81.6% |
| Q4 25 | 2.4% | 11.4% | ||
| Q3 25 | 2.3% | 2.6% | ||
| Q2 25 | 4.1% | 1.5% | ||
| Q1 25 | 6.8% | 1.3% | ||
| Q4 24 | 28.0% | 5.3% | ||
| Q3 24 | 45.7% | 1.2% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 23.62× | ||
| Q2 25 | — | 7.22× | ||
| Q1 25 | — | -10.01× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 5.90× | ||
| Q2 24 | — | 6.00× | ||
| Q1 24 | — | -8.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IBRX
Segment breakdown not available.
SAMG
| Investment Advisory Management And Administrative Service | $30.7M | 96% |
| Tax And Family Office Services | $1.2M | 4% |
